Literature DB >> 16477242

Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.

Evangelos Cholongitas, Dimitrios Samonakis, David Patch, Marco Senzolo, Andrew Kenneth Burroughs, Alberto Quaglia, Amar Dhillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16477242     DOI： 10.1097/01.tp.0000196716.07188.c4

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  12 in total

1.  Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival.

Authors:  Pratima Sharma; Amy Hosmer; Henry Appelman; Barbara McKenna; Mohammad S Jafri; Patricia Sullivan; Robert J Fontana; Anna S Lok
Journal:  Hepatol Int       Date:  2013-10       Impact factor: 6.047

Review 2.  De novo autoimmune hepatitis in liver transplant: State-of-the-art review.

Authors:  Ranka Vukotic; Giovanni Vitale; Antonia D'Errico-Grigioni; Luigi Muratori; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 3.  Autoimmune Hepatitis in the Liver Transplant Graft.

Authors:  Eliza W Beal; Sylvester M Black; Anthony Michaels
Journal:  Clin Liver Dis       Date:  2017-05       Impact factor: 6.126

4.  De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.

Authors:  Kazuki Takeishi; Ken Shirabe; Takeo Toshima; Toru Ikegami; Kazutoyo Morita; Takasuke Fukuhara; Takashi Motomura; Yohei Mano; Hideaki Uchiyama; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

5.  Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation.

Authors:  Francesca Romana Ponziani; Eleonora Brigida Annicchiarico; Massimo Siciliano; Francesca D'Aversa; Maurizio Pompili; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

6.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

Review 7.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 8.  Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.

Authors:  Jan Peveling-Oberhag; Stefan Zeuzem; Wolf Peter Hofmann
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402

9.  Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Koji Fukushima; Futoshi Nagasaki; Jun Inoue; Eiji Kakazu; Yasunori Matsuda; Osamu Kido; Yu Nakagome; Osamu Kimura; Noriyuki Obara; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

10.  Liver transplantation and hepatitis C.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Int J Hepatol       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.